Many of the technological inventions developed at the University Twente originate from scientific projects aimed at technological, chemical and industrial progress. Inventions or breakthroughs based on these types of research are often technology driven and do not necessarily result in successful health care innovations. In a situation where new medical technologies are competing for resources, a tool to prioritize the innovations most likely to succeed is indisputably valuable.

The potential of an innovation is its inherent ability to innovate and be implemented the health care system. Among others, it is determined by its effects on health (expected health gain, unmet needs); user needs, wants and preferences (patients, doctors and insurers); its expected monetary impact (cost-effectiveness, system spending), the strengths and weaknesses of the competition and any regulation facilitating or hindering penetration of the market (market access, coverage, reimbursement). It is sensible for a company considering the development of a new medical technology to assess these factors as early as possible in the development cycle[i].

The objective of this project is to determine the potential of health care inventions (specifically, devices developed within the High Tech Health Farm) by using a tested and validated framework for technology assessment in early stages of development. The index of an innovation is defined as the likelihood that an innovation, as judged in its early stages of development, will be successfully introduced into the market.

The funding organisation for this project is the province of Overijssel, within the High Tech Health Farm Project. In this project, the HTA and business development of the clinical applications that are being developed will be supported.